R26Phospho-mTOR expression levels, proliferative acitivity...

Annals of Oncology 2015 / 10 Vol. 26; Iss. suppl 6

R26Phospho-mTOR expression levels, proliferative acitivity (Ki67) and pancreatic primary tumor may influence the response to everolimus in neuroendocrine tumor patients: results from an Italian preliminary study

Birocco, N., Brizzi, M.P., Airoldi, M., De Angelis, C., Maletta, F., Piovesan, A., Rapa, I., Sapino, A., Scaldaferri, M., Scagliotti, G., Papotti, M., Volante, M.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv348.26
Date:
October, 2015
File:
PDF, 30 KB
english, 2015
Conversion to is in progress
Conversion to is failed